Critical congenital heart disease (CCHD) screening was added to the US Recommended Uniform Screening Panel in 2011 and adopted by all US states and territories by 2018. In addition to reviewing key developments in CCHD screening since the initial American Academy of Pediatrics (AAP) endorsement in 2011, this clinical report provides 3 updated recommendations. First, a new AAP algorithm has been endorsed for use in CCHD screening. Compared with the original AAP algorithm from 2011, this new algorithm a) has a passing oxygen saturation threshold of ≥95% in both pre- and post-ductal measurements; and b) has only 1 retest instead of 2 for infants who did not pass the first screen. Second, to continue to improve screening, state newborn screening programs should collect a recommended minimum uniform dataset to aid in surveillance and monitoring of the program. Finally, stakeholders should be educated on the limitations of screening, the significance of non-CCHD conditions, and the importance of protocol adherence. Future directions of CCHD screening include improving overall sensitivity and implementing methods to reduce health inequities. It will remain critical that the AAP and its chapters and members work with health departments and hospitals to achieve awareness and implementation of these recommendations.

中文翻译：

---

危重先天性心脏病的新生儿筛查：新算法和其他更新建议：临床报告。


危重先天性心脏病 （CCHD） 筛查于 2011 年被添加到美国推荐的统一筛查小组中，并于 2018 年被美国所有州和地区采用。除了回顾自 2011 年美国儿科学会 （AAP） 首次认可以来 CCHD 筛查的主要进展外，本临床报告还提供了 3 条更新的建议。首先，一种新的 AAP 算法已被认可用于 CCHD 筛查。与 2011 年的原始 AAP 算法相比，这种新算法 a） 在导管前和导管后测量中的氧饱和度阈值为 ≥95%;b） 对于未通过第一次筛查的婴儿，只有 1 次复测，而不是 2 次。其次，为了继续改进筛查，各州新生儿筛查计划应收集建议的最低统一数据集，以帮助监测和监测该计划。最后，应教育利益相关者了解筛查的局限性、非 CCHD 疾病的重要性以及方案依从性的重要性。CCHD 筛查的未来方向包括提高整体敏感性和实施减少健康不平等的方法。AAP 及其分会和成员与卫生部门和医院合作，以实现对这些建议的认识和实施仍然至关重要。